Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer
Yoshinaga Okugawa(Mie University Hospital), Masato Kusunoki(Mie University), Hiroyuki Fujikawa(Hospital d'Igualada), Akira Yamamoto(Juntendo University), Junichiro Hiro(Fujita Health University), Yuji Toiyama(Mie University), Chengzeng Yin(Mie University), Takashi Ichikawa(ETH Zurich), Donald C. McMillan(Glasgow Royal Infirmary), Akihiro Suzuki(St. Luke's International Hospital), Toshimitsu Araki(Mie University), Shigeyuki Yoshiyama(Mie University), Masaki Ohi(Mie University), Hiromi Yasuda(Mie University), Tsunehiko Shigemori(Mie University)
Cited by 144
Related Papers
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
|Gastroenterology|2015|814
An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
|British Journal of Cancer|2011|526
Readily Available Biaryl P,N Ligands for Asymmetric Catalysis
|Angewandte Chemie International Edition|2004|378
Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy
|Annals of Surgical Oncology|2009|324